logo
logo
Mobile Header

Clinical Safety and Pharmacovigilance

Program Overview

The Clinical Safety and Pharmacovigilance Certificate Program is designed to develop specialized knowledge and skills required to; write study protocols, monitor and manage clinical trials, and to conduct drug safety and pharmacovigilance activities. This hands-on training approach includes drafting adverse reaction reports and preparing periodic safety update reports.

The program focuses on the global healthcare system as well as the Canadian healthcare system, Canadian regulatory agencies, health care legislation, international guidelines, and standard operating procedures (SOP). Using practical and current real cases, AAPS integrates a unique approach and provides students with the foundation and practical knowledge to formulate a sound clinical development plan; ensure clinical trial data is credible and accurate; and that the rights, integrity and confidentiality of trial subjects are protected.

A well-trained and knowledgeable Clinical Research and Pharmacovigilance professional plays a vital role in protecting the study participant and the general population for marketed drugs and in helping to reduce the time between drug development and marketing approval. The demand for knowledgeable and trained Clinical Research and Pharmacovigilance professionals continues to grow, as supply is limited.


The program focuses on topics delivered through 15 modules: 

  • The Canadian Pharmaceutical Industry: Big Picture
  • Introduction to Clinical Research and Drug Safety
  • Legislations, Guidelines and Ethics in Clinical Research and Drug Safety
  • Introduction to Statistical Analysis
  • Clinical Research Regulations and Good Clinical Practices (GCP)
  • Pharmaceutical Biotechnology
  • Medical Devices
  • Organization of Clinical Trials and Clinical Monitoring Plan Development
  • Clinical Project Management and Project Chart Development
  • Clinical Data Acquisition and Data Management
  • Clinical Research SOP Development
  • Clinical Study Protocol and Investigator’s Brochure Development
  • GCP and GVP Inspections and Audits
  • Global Clinical Research and Pharmacovigilance
  • Clinical Research, Drug Safety and Pharmacovigilance Project

    A well-trained and knowledgeable Drug Safety and Pharmacovigilance professional plays a vital role in protecting the study participant and the general population for marketed drugs and in helping to reduce the time between drug development and marketing approval.

    Certifications

    Successful candidates will also receive certificate per completed module:

    • The Canadian Pharmaceutical Industry: Big Picture
    • Introduction to Clinical Research and Drug Safety
    • Legislations, Guidelines and Ethics in Clinical Research and Drug Safety
    • Introduction to Statistical Analysis
    • Clinical Research Regulations and Good Clinical Practices (GCP)
    • Pharmaceutical Biotechnology
    • Medical Devices
    • Organization of Clinical Trials and Clinical Monitoring Plan Development
    • Clinical Project Management and Project Chart Development
    • Clinical Data Acquisition and Data Management
    • Clinical Research SOP Development
    • Clinical Study Protocol and Investigator’s Brochure Development
    • GCP and GVP Inspections and Audits
    • Global Clinical Research and Pharmacovigilance
    • Clinical Research, Drug Safety and Pharmacovigilance Project

    To register for in-class, contact us via telephone at 416-502-2277 or by email at info@aaps.ca.

    Interested in AAPS? Contact us directly or provide your information for a call back.

    Toronto Campus

    885 Sheppard Avenue West Toronto, Ontario M3H 2T4, Canada

    Open Hours

    Mon-Fri 8:30am - 5:00pm Sat - by appointment only

    Mississauga Campus

    2960 Drew Road Unit 140, Mississauga, Ontario L4T 0A5, Canada

    Open Hours

    Mon-Fri 8:30am - 5:00pm
    Telephone: 416-502-2277 Toll Free: 1-855-502-2288 Email: info@aaps.ca
    I consent to be contacted by Academy of Applied Pharmaceutical Sciences and I understand that I can opt-out later

    Connect with AAPS